Association for Molecular Pathology (AMP) News, Meetings & Events http://www.amp.org Association for Molecular Pathology en-us Wed, 16 May 2012 15:54:09 -0400 cwallington@asip.org Wed, 16 May 2012 15:52:13 -0400 FeedForAll v2.0 (2.0.3.1) http://www.feedforall.com Registration for the AMP 2012 Annual Meeting on Genomic Medicine and the Molecular Pathology Outreach Course are now open. http://www.amp.org/meetings/2012/registration.cfm 7E7AE382-74CE-472E-A338-F3C091F74B67 Wed, 16 May 2012 15:52:13 -0400 The goal of the group is to produce a white paper that will outline the key issues, and provide AMP's recommendations for future LDT oversight. http://www.amp.org/documents/050212_LDTWorkGroup.pdf 7310BE2F-BBC4-402D-B40B-DAFEC9456196 Wed, 2 May 2012 15:51:31 -0400 AMP is optimistic that it will ultimately prevail in its lawsuit to invalidate patents on two genes that are known to cause breast cancer. http://www.amp.org/documents/032712_AMPvMyriad_SupremeCourtDecision.pdf 18D3E99D-B624-427E-BF95-5D79BBC706B9 Tue, 27 Mar 2012 15:50:42 -0400 March 2012: "Prometheus acknowledged that physicians can infringe the patent by merely thinking about the relationship between drug metabolite levels and patient response," stated Dr. Iris Schrijver. http://www.amp.org/about/press_releases/documents/032112_Prometheus.pdf 6B2E21EE-7EFE-4ABA-9ADA-A862820B74B8 Wed, 21 Mar 2012 09:06:44 -0400 March 2012: AMP is optimistic that it will ultimately prevail in its lawsuit to invalidate patents on two genes that are known to cause breast cancer. http://www.amp.org/documents/032712_AMPvMyriad_SupremeCourtDecision.pdf 75C8E5B1-3269-4CCA-B0FC-5C33CE03D4FE Tue, 27 Mar 2012 09:05:07 -0400 AMP testified at the U.S. Patent and Trademark Office hearing regarding patents on human genes. http://www.amp.org/documents/021612_USPTOTestimony.pdf 397AAE10-A696-492C-B19B-B592C06B9524 Thu, 16 Feb 2012 10:20:15 -0500 AMP is optimistic the Supreme Court will follow its precedents that render natural products, natural laws, and natural phenomena ineligible for patent protection. http://www.amp.org/documents/AMPSCOTUSRelease_Final.pdf 4D7674FE-7A3E-426E-978A-A956F7738B47 Tue, 13 Dec 2005 08:44:07 -0500 The CAP Pathology and Laboratory Quality Center partnered with the IASLC and AMP to determine proper test selection and techniques for non-small cell lung cancer biomarker tests, better ensuring appropriate therapies for lung cancer patients. The CAP/IASLC/AMP Lung Cancer Biomarkers guideline provides evidence-based recommendations for the molecular testing of lung cancer. Review the draft recommendations and post your comments by Monday, December 19 at the CAP website. http://www.cap.org/apps/docs/membership/transformation/new/expertise.html 9916FF15-D02D-49B0-BB2C-FCC6EA015202 Mon, 19 Dec 2011 06:04:16 -0500 November 2011: AMP Responds to the NIH on the proposal to exclusively license the subject matter of a cancer-related proteonomics patent application filed by the Agency titled "Prospective Grant of Exclusive License: The Development of a Companion Diagnostic Kit for Predicting Therapeutic Efficacy of Anti-Cancer Agents." http://www.amp.org/about/press_releases/index.cfm 76CAC877-A7C9-4E75-9DBF-3430AE22BC67 Tue, 1 Nov 2011 06:05:27 -0500 The AMP Program Committee would like your suggestions for potential program topics for the AMP 2012 Annual Meeting, to be held October 25-27, 2012, at the Long Beach Convention & Entertainment Center, in Long Beach, CA. Deadline to submit is December 31, 2011. http://www.amp.org/forms/AMP_2012_CallforSessionTopics.cfm 80417BF9-251F-4B15-B0A0-EA9E4A8C4C34 Thu, 1 Dec 2011 06:06:25 -0500 October 2011: AMP submits comments to the HHS on the advanced notice of proposed rulemaking (ANPRM) titled, "Human Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators." http://www.amp.org/documents/ANPRM_ResearchProtections_Oct2011.pdf EBD32FFF-5F35-4046-B95F-E94686673AA2 Mon, 24 Oct 2011 06:13:25 -0500 September 20, 2011: AMP urged the Joint Select Committee on Deficit Reduction to explore fiscally responsible ways to sustain funding for graduate medical education (GME) and opposed any cuts to this vital funding http://www.amp.org/documents/AMPGMELetter_JointCmte_Sep2011_000.pdf 9BCCFA0D-8668-4557-BCF3-26EA18925119 Tue, 20 Sep 2011 06:13:56 -0500 We invite you to attend the Association for Molecular Pathology (AMP) 17th Annual Meeting and Exhibits November 17-19, 2011, at the Gaylord Texan Resort and Convention Center in Grapevine, TX. Programming includes poster sessions and invited speakers for workshop and plenary sessions in the major areas of clinical molecular diagnostics: hematopathology, infectious diseases, inherited genetic diseases, solid tumors, and technical topics. http://www.amp.org/meetings/2011/ 223DFCC4-732D-4639-AFD1-B8A9BB641363 Tue, 8 Mar 2011 06:25:38 -0500 This one-day course is designed for pathologists, laboratory directors and technologists who have little experience with molecular diagnostic testing. November 17, 2011 at the Gaylord Texan Resort & Convention Center, Grapevine, Texas. http://www.amp.org/meetings/2011/mpoc/ D2552D61-E22F-4678-92AB-33C26B96DFAC Tue, 8 Mar 2011 06:26:00 -0500